期刊文献+

κ-阿片受体在抑制心肌肥厚中的作用 被引量:2

The inhibitory effects of κ-opioid receptor on cardiac hypertrophy
暂未订购
导出
摘要 目的与方法 :在儿茶酚胺诱导的大鼠心肌肥厚及培养的心肌细胞中 ,观察 κ-阿片受体选择性激动剂 U5 0 ,4 88H对心肌肥厚及心肌细胞生长的作用。结果 :大鼠静脉注射异丙肾上腺素 2周 (3mg· kg- 1· d- 1 )发生心肌肥厚 ,表现为心脏重量指数明显增加 ,光镜和电镜显示明确的肥厚性组织病理学改变。 U5 0 ,4 88H可明显改善这些异常改变。且对去甲肾上腺素引起的促心肌细胞生长具有明显的抑制作用。结论 AIM and METHODS: To investigate the effects of U50,488H (a selective κ opioid receptor agonist) on cardiac hypertrophy and cardiac cells growth induced by catecholamine. RESULTS: The cardiac hypertrophy was developed following isoproterenol ((3 mg·kg -1 ·d -1 )intravenously for 2 weeks. The cardiac weight index increased significantly with the hypertrophic alteration in light micrographs of cardiac tissue and transmission electron micrographs of myocardial ultrastructure. Administered U50,488H significantly attenuated these abnormal changes and markedly inhibited the cardiac cells growth stimulated by norepinephrine. CONCLUSION: κ opioid peptide attenuates the cardiac hypertrophy, and κ opioid receptor plays an important negatively role in the development of cardiac hyperytrophy and cell growth.
出处 《心脏杂志》 CAS 2002年第6期465-468,共4页 Chinese Heart Journal
基金 军队医药卫生"十五"课题基金 (0 1M12 9) 第四军医大学创新工程重点项目基金 (CX0 1F 0 0 1)
关键词 Κ-阿片受体 抑制 心肌肥厚 作用 细胞培养 治疗 receptor,κ opioid U50,488H cardiac hypertrophy cell culture
  • 相关文献

参考文献11

  • 1Ventura C, Guarnieri C, Vaona I, et al. Dynorphin gene expression and release in the myocardial cell[J]. J Biol Chem, 1994,269: 5384-5386.
  • 2Krumins SA, Faden AL, Feuerstein G. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock[J]. Biochem Biophys Res Comm, 1985,127: 120-128.
  • 3McLaughlin PJ. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by[Met5]enkephalin[J]. Am J Physiol, 1996,271: R122- R129.
  • 4Pepe S, Xiao RP, Hohl C, et al. `Cross Talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart[J]. Circulation, 1997, 95: 2122-2129.
  • 5Yu XC, Wang HX, Zhang WM, et al. Cross-talk between cardiac κ-opioid and β-adrenergic receptors in developing hypertensive rats[J]. J Mol Cell Cardiol, 1999, 31: 597-605.
  • 6陈迈,裴建明,李兰荪,王跃民,范谦,黄德明.U50,488H对大鼠腹主动脉的舒张作用及其机制[J].第四军医大学学报,2001,22(1):29-32. 被引量:13
  • 7Sandoshima J, Isumo S. The cellular and molecular response of cardiac myocyte to mechanical stress[J]. Annu Rev Physiol, 1997, 59:551-571.
  • 8Pei JM, Zhou JJ, Bian JS, et al. Impaired[Ca2+]i and pHi responses to κ-opioid receptor stimulation in the heart of chronically hypoxic rats[J]. Am J Physiol (Cell Physiol), 2000, 279: C1483-C1494.
  • 9Pei JM, Wang YM, Chen M, et al. Signaling pathway mediated by κ-opioid receptor is impaired in cardiac hypertrophy[J]. Acta Pharmacologica Sinica, 2001,22(10):865-960.
  • 10Ventura C, Spurgeon H, Lakatta EG, et al.κ and δ opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons[J]. Circ Res,1992, 70: 66-81.

二级参考文献11

  • 1Wu S,Circulation Research,1999年,84卷,1388页
  • 2Yu X C,J Mol Cell Cardiol,1999年,31卷,1809页
  • 3Yu X C,J Mol Cell Cardiol,1999年,31卷,597页
  • 4Bian J S,J Mol Cell Cardiol,1998年,30卷,2103页
  • 5Yu X C,J Mol Cell Cardiol,1998年,30卷,405页
  • 6Zhang W M,Br J Pharmacol,1997年,120卷,827页
  • 7Schultz J J,Circulation Research,1996年,78卷,1100页
  • 8Sheng J Z,Acta Pharmacol Sin,1994年,15卷,1期,36页
  • 9Xia Q,J Pharmacol Exp Ther,1994年,268卷,930页
  • 10Lin S X,动物学报,1992年,38卷,2期,202页

共引文献12

同被引文献24

  • 1王洪新,陶亮,饶曼人.血管紧张素Ⅱ对培养乳鼠非心肌细胞DNA及蛋白合成的影响[J].中国药理学通报,1996,12(5):417-420. 被引量:11
  • 2杨彦玲 王洪新 杨玲.Kappa阿片受体激动对去甲肾上腺素诱导的心肌肥大的抑制作用[J].中国药理学通报,2001,18:91-4.
  • 3Messerli FH, Aristizabal D, Soria F. Reduction of left ventricular hypertrophy: How beneficial[J] . Am Heart J, 1993; 125:1520 - 4
  • 4Levy D, Garrison R J, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study[ J]. N Engl J Med, 1990; 323:1706 - 7
  • 5Wang G, Wang H, Yang Y, Wong TM. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes [J]. EurJ Pharmacol. 2004;13;498:53-8
  • 6Utz J, Eckert R, Trautwein W. Inhibition of L-type calcium current in guinea pig ventricular myocytes by kappa-opioid agonist U50,488H does not involve binding to opiate receptors[ J].J Pharmacol Exp Ther, 1995;274:627- 33
  • 7Barrallo A, Gonzales-Sarmiento R, Santos Mv, Barrallo A,Gonzalez-Sarmiento R, Santos MV, et al. RT-PCR detection of opioid receptor Mrna in different tissues [ J ]. Analgesia.1995;1:1272-7
  • 8Yu XC, Li HY, Wang HX, Wong TM. U50,488H inhibits effect of Norepinephrine in rat cardiomyocytes-cross talk between κ-opioid and β-adrenergic receptors[J]. J Mol Cell Cardiol,1998; 30:405- 13
  • 9Barron BA. Opioid peptides and the heart[J]. Cardiovasc Res, 1999, 43(1):13-16.
  • 10Yu XC, Li HY, Wang HX, Wong TM. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors[J]. J Mol Cell Cardiol, 1998, 30(2):405-413.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部